ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases. 

Biotechnology

ReCode Therapeutics

Shehnaaz Suliman

Erica V. Jefferson

John G. Matthews

Joe Cefalu

Teri Keffer

Rana Al-Hallaq

Marina Matkova Ristov

Eneda Hoxha

DeJuan L. Owens

Daniel Siegwart

Heather Clark

Shuang Li

Sakya Mohapatra

April Loui

David J Lockhart

Vladimir G. Kharitonov

Angèle Maki

The Research and Development team at ReCode Therapeutics focuses on discovering and advancing innovative genetic therapies for respiratory diseases. By integrating preclinical biology, clinical development, and strategic operations, they aim to develop targeted treatments that significantly improve patient outcomes.

Research and Development

Directors Team

Leadership Team

Research and Development

About

Team members

Other teams at ReCode Therapeutics

Research and Development

Directors Team

Leadership Team